Serum CD40/CD40L System in Graves' Disease and Hashimoto's Thyroiditis Related to Soluble Fas, FasL and Humoral Markers of Autoimmune Response

By Mysliwiec Janusz   Oklota Magdalena   Nikolajuk Agnieszka   Waligorski Dariusz   Gorska Maria  

Immunological Investigations, Vol. 36, Iss. 3, 2007-05 ,pp. : 247-257

Informa Healthcare

Access to resources Recommend Favorite

Identification of New Fas Mutations in a Patient with Autoimmune Lymphoproliferative Syndrome (ALPS) and Eosinophilia

By Aspinall A.I.   Pinto A.   Auer I.A.   Bridges P.   Luider J.   Dimnik L.   Patel K.D.   Jorgenson K.   Beutler R.E.C.  

Blood Cells, Molecules, and Diseases, Vol. 25, Iss. 4, 1999-08 ,pp. : 227-238

Academic Press

Access to resources Recommend Favorite

Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease

By Wang Duncheng  

International Immunology, Vol. 17, Iss. 9, 2005-09 ,pp. : 1179-1191

Oxford University Press

Access to resources Recommend Favorite

Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder

By Koizumi F.  

International Immunology, Vol. 10, Iss. 2, 1998-02 ,pp. : 195-202

Oxford University Press

Access to resources Recommend Favorite

Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease

By Peters A.M.J.   Kohfink B.   Martin H.   Griesinger F.   Wormann B.   Gahr M.   Roesler J.  

Experimental Hematology, Vol. 27, Iss. 5, 1999-05 ,pp. : 868-874

Elsevier

Access to resources Recommend Favorite